Sweden · Delayed Price · Currency is SEK Nobia AB Earnings Call Transcripts
Fiscal Year 2026
-
Q1 saw key milestones: U.K. divestment, a SEK 1.5B rights issue, and Nobia Park ramp-up. Organic growth reached 2% with improved margins, while B2B showed early recovery signs. Net debt fell to SEK 1.7B, and cost-saving programs are set to boost profitability.
-
Announced divestment of U.K. operations, a SEK 1.5 billion rights issue, and refinancing to focus on the Nordic market. Strategic investments and restructuring aim to boost margins, reduce leverage, and position for growth as the market recovers.
Fiscal Year 2025
-
Divestment of UK operations and a SEK 1.5 billion rights issue strengthen focus on Nordic brands and balance sheet. Q4 saw 3% organic growth, improved margins, and ongoing supply chain transformation, with further cost savings and margin expansion targeted for 2026.
-
Operating performance and cash flow improved despite a 3% organic sales decline, with gross margin up to 38.6% and significant cost savings realized. SEK 1.9 billion non-cash impairment was recorded for U.K. operations, and strategic reviews continue amid soft market conditions.
-
EBIT, EBIT margin, and cash flow improved despite a 5% organic sales decline, driven by cost savings and consumer segment growth. Nordic EBIT margin reached 8.9%, while UK losses narrowed. Strategic initiatives and supply chain transformation continue amid challenging markets.
-
Positive EBIT and record gross margin were achieved, driven by strong Nordic performance and cost savings, while the U.K. segment remains challenged by project market softness and restructuring. Cash flow and net debt improved, with further savings and investments planned for 2025.
Fiscal Year 2024
-
Q4 delivered improved profitability, especially in the Nordics, despite ongoing project market weakness. Cost savings, a stronger gross margin, and progress in the Jönköping factory and U.K. restructuring supported results, with further savings and operational improvements targeted for 2025.
-
Q3 saw a 6% organic sales decline, with strong consumer recovery offset by weak project markets. Gross margin improved in the Nordics, while cost reductions and the Jönköping factory ramp-up remain key priorities for 2025.
-
Organic growth declined 3% year-over-year, with project segments weak but retail showing early recovery, especially in the UK and Denmark. EBIT and gross margin improved, supported by cost programs and strategic investments, while further cost reductions and efficiency measures are planned.